Insider Buy/Sell Details for the Biotechnology Industry — August 2026
Ratio0.1:1
Daily Buy & Sell Volume
Transactions (333)
BeOne Medicines Ltd. (ONC)
OYLER JOHN — Director
Shares
14,102
Price
$359.12
Total Value
$5.06M
Shares Held After
0
% of Holdings
100.0%
BeOne Medicines Ltd. (ONC)
OYLER JOHN — Director
Shares
20,899
Price
$358.41
Total Value
$7.49M
Shares Held After
14,102
% of Holdings
59.7%
BeOne Medicines Ltd. (ONC)
OYLER JOHN — Director
Shares
15,396
Price
$357.63
Total Value
$5.51M
Shares Held After
35,001
% of Holdings
30.5%
BeOne Medicines Ltd. (ONC)
OYLER JOHN — Director
Shares
2,515
Price
$356.43
Total Value
$896.43K
Shares Held After
50,397
% of Holdings
4.8%
BeOne Medicines Ltd. (ONC)
OYLER JOHN — Director
Shares
1,980
Price
$354.71
Total Value
$702.32K
Shares Held After
52,912
% of Holdings
3.6%
Immunome Inc. (IMNM)
Barchas Isaac — Director
Shares
11,048
Price
$27.25
Total Value
$301.06K
Shares Held After
92,211
% of Holdings
10.7%
Xeris Biopharma Holdings, Inc. (XERS)
Pieper Steven — Chief Financial Officer
Shares
5,000
Price
$8.50
Total Value
$42.50K
Shares Held After
1,361,053
% of Holdings
0.4%
Sagimet Biosciences Inc. (SGMT)
Kemble George — Director
Shares
20,206
Price
$9.95
Total Value
$201.15K
Shares Held After
62,161
% of Holdings
24.5%
Protagenic Therapeutics, Inc.\new (PTIX)
ARMEN GARO H — Director
Shares
2,220
Price
$0.32
Total Value
$710.40
Shares Held After
34,199
% of Holdings
6.5%
Protagonist Therapeutics, Inc (PTGX)
PATEL DINESH V PH D — Director
Shares
34,239
Price
$148.52
Total Value
$5.09M
Shares Held After
523,478
% of Holdings
6.1%
BeOne Medicines Ltd. (ONC)
OYLER JOHN — Director
Shares
4
Price
$367.00
Total Value
$1.47K
Shares Held After
54,892
% of Holdings
0.0%
BeOne Medicines Ltd. (ONC)
OYLER JOHN — Director
Shares
1,200
Price
$366.31
Total Value
$439.57K
Shares Held After
54,896
% of Holdings
2.1%
BeOne Medicines Ltd. (ONC)
OYLER JOHN — Director
Shares
3,176
Price
$365.26
Total Value
$1.16M
Shares Held After
56,096
% of Holdings
5.4%
BeOne Medicines Ltd. (ONC)
OYLER JOHN — Director
Shares
5,211
Price
$364.31
Total Value
$1.90M
Shares Held After
59,272
% of Holdings
8.1%
BeOne Medicines Ltd. (ONC)
OYLER JOHN — Director
Shares
13,403
Price
$363.45
Total Value
$4.87M
Shares Held After
64,483
% of Holdings
17.2%
BeOne Medicines Ltd. (ONC)
OYLER JOHN — Director
Shares
11,568
Price
$362.34
Total Value
$4.19M
Shares Held After
77,886
% of Holdings
12.9%
BeOne Medicines Ltd. (ONC)
OYLER JOHN — Director
Shares
14,569
Price
$361.47
Total Value
$5.27M
Shares Held After
89,454
% of Holdings
14.0%
BeOne Medicines Ltd. (ONC)
OYLER JOHN — Director
Shares
8,081
Price
$360.33
Total Value
$2.91M
Shares Held After
104,023
% of Holdings
7.2%
BeOne Medicines Ltd. (ONC)
OYLER JOHN — Director
Shares
13,695
Price
$359.32
Total Value
$4.92M
Shares Held After
112,104
% of Holdings
10.9%
Immunome Inc. (IMNM)
Barchas Isaac — Director
Shares
62,291
Price
$26.23
Total Value
$1.63M
Shares Held After
0
% of Holdings
100.0%
Mirum Pharmaceuticals, Inc. (MIRM)
BJERKHOLT ERIC — CHIEF FINANCIAL OFFICER
Shares
6,001
Price
$99.90
Total Value
$599.51K
Shares Held After
36,355
% of Holdings
14.2%
Avalo Therapeutics, Inc. (AVTX)
Riley Jennifer — Chief Strategy Officer
Shares
2,655
Price
$19.59
Total Value
$52.01K
Shares Held After
37,041
% of Holdings
6.7%
Corbus Pharmaceuticals Holdings, Inc. (CRBP)
Saxena Nishant C — Chief Business Officer
Shares
2,600
Price
$9.63
Total Value
$25.04K
Shares Held After
77,900
% of Holdings
3.3%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
280
Price
$531.01
Total Value
$148.68K
Shares Held After
324,443
% of Holdings
0.1%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
143
Price
$529.05
Total Value
$75.65K
Shares Held After
324,723
% of Holdings
0.0%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
737
Price
$528.07
Total Value
$389.19K
Shares Held After
324,866
% of Holdings
0.2%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
935
Price
$527.16
Total Value
$492.90K
Shares Held After
325,603
% of Holdings
0.3%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
2,725
Price
$526.05
Total Value
$1.43M
Shares Held After
326,538
% of Holdings
0.8%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
871
Price
$525.19
Total Value
$457.44K
Shares Held After
329,263
% of Holdings
0.3%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
379
Price
$524.13
Total Value
$198.65K
Shares Held After
330,134
% of Holdings
0.1%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
221
Price
$523.04
Total Value
$115.59K
Shares Held After
330,513
% of Holdings
0.1%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
200
Price
$521.73
Total Value
$104.35K
Shares Held After
330,734
% of Holdings
0.1%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
200
Price
$520.59
Total Value
$104.12K
Shares Held After
330,934
% of Holdings
0.1%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
120
Price
$518.95
Total Value
$62.27K
Shares Held After
331,134
% of Holdings
0.0%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
120
Price
$517.57
Total Value
$62.11K
Shares Held After
331,254
% of Holdings
0.0%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
520
Price
$516.91
Total Value
$268.79K
Shares Held After
331,374
% of Holdings
0.2%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
360
Price
$515.52
Total Value
$185.59K
Shares Held After
331,894
% of Holdings
0.1%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
1,214
Price
$514.52
Total Value
$624.63K
Shares Held After
332,254
% of Holdings
0.4%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
475
Price
$513.37
Total Value
$243.85K
Shares Held After
333,468
% of Holdings
0.1%
Rapport Therapeutics, Inc. (RAPP)
Ceesay Abraham — Director
Shares
5,794
Price
$48.62
Total Value
$281.72K
Shares Held After
486,108
% of Holdings
1.2%
Rapport Therapeutics, Inc. (RAPP)
Ceesay Abraham — Director
Shares
19,500
Price
$48.04
Total Value
$936.85K
Shares Held After
491,902
% of Holdings
3.8%
Rapport Therapeutics, Inc. (RAPP)
Ceesay Abraham — Director
Shares
3,664
Price
$46.90
Total Value
$171.84K
Shares Held After
511,402
% of Holdings
0.7%
Alpha Tau Medical Ltd. (DRTS)
Levy Raphi — Chief Financial Officer
Shares
17,730
Price
$14.00
Total Value
$248.28K
Shares Held After
90,180
% of Holdings
16.4%
Mineralys Therapeutics, Inc. (MLYS)
Rodman David Malcom — Chief Medical Officer
Shares
2,170
Price
$27.09
Total Value
$58.79K
Shares Held After
51,384
% of Holdings
4.1%
Adaptive Biotechnologies Corp (ADPT)
BOBULSKY SUSAN — Chief Commercial Officer, MRD
Shares
3,000
Price
$25.00
Total Value
$75.00K
Shares Held After
396,989
% of Holdings
0.8%
EXELIXIS, INC. (EXEL)
Beckerle Mary C — Director
Shares
9,812
Price
$53.66
Total Value
$526.51K
Shares Held After
16,079
% of Holdings
37.9%
Protagonist Therapeutics, Inc (PTGX)
PATEL DINESH V PH D — Director
Shares
65,761
Price
$149.11
Total Value
$9.81M
Shares Held After
523,478
% of Holdings
11.2%
BeOne Medicines Ltd. (ONC)
OYLER JOHN — Director
Shares
3,680
Price
$360.63
Total Value
$1.33M
Shares Held After
125,799
% of Holdings
2.8%
BeOne Medicines Ltd. (ONC)
OYLER JOHN — Director
Shares
21,254
Price
$359.50
Total Value
$7.64M
Shares Held After
129,479
% of Holdings
14.1%
BeOne Medicines Ltd. (ONC)
OYLER JOHN — Director
Shares
45,044
Price
$358.70
Total Value
$16.16M
Shares Held After
150,733
% of Holdings
23.0%
Showing 1–50 of 333 transactions (page 1 of 7)